| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-57 |
Sentence |
denotes |
Etiology of Paget's disease and osteoclast abnormalities. |
| T1 |
0-57 |
Sentence |
denotes |
Etiology of Paget's disease and osteoclast abnormalities. |
| TextSentencer_T2 |
58-186 |
Sentence |
denotes |
Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years. |
| T2 |
58-186 |
Sentence |
denotes |
Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years. |
| TextSentencer_T3 |
187-244 |
Sentence |
denotes |
Paget's disease is primarily a disease of the osteoclast. |
| T3 |
187-244 |
Sentence |
denotes |
Paget's disease is primarily a disease of the osteoclast. |
| TextSentencer_T4 |
245-424 |
Sentence |
denotes |
The pathologic abnormality in patients with Paget's disease involves increased bone resorption by the osteoclasts, followed by abundant new bone formation that is of poor quality. |
| T4 |
245-424 |
Sentence |
denotes |
The pathologic abnormality in patients with Paget's disease involves increased bone resorption by the osteoclasts, followed by abundant new bone formation that is of poor quality. |
| TextSentencer_T5 |
425-581 |
Sentence |
denotes |
Genetic linkage analysis indicated that 40% of patients with Paget's disease have an affected first degree relative and 1% of patients develop osteosarcoma. |
| T5 |
425-581 |
Sentence |
denotes |
Genetic linkage analysis indicated that 40% of patients with Paget's disease have an affected first degree relative and 1% of patients develop osteosarcoma. |
| TextSentencer_T6 |
582-656 |
Sentence |
denotes |
Paget's disease is an autosomal dominant trait with genetic heterogeneity. |
| T6 |
582-656 |
Sentence |
denotes |
Paget's disease is an autosomal dominant trait with genetic heterogeneity. |
| TextSentencer_T7 |
657-797 |
Sentence |
denotes |
Recurrent mutations in the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTM1/p62) are identified in patients with Paget's disease. |
| T7 |
657-797 |
Sentence |
denotes |
Recurrent mutations in the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTM1/p62) are identified in patients with Paget's disease. |
| TextSentencer_T8 |
798-972 |
Sentence |
denotes |
Osteoclasts and osteoclast precursors from patients with Paget's disease contain paramyxoviral transcripts and appear hyperresponsive to 1,25-(OH)2D3 and RANK ligand (RANKL). |
| T8 |
798-972 |
Sentence |
denotes |
Osteoclasts and osteoclast precursors from patients with Paget's disease contain paramyxoviral transcripts and appear hyperresponsive to 1,25-(OH)2D3 and RANK ligand (RANKL). |
| TextSentencer_T9 |
973-1164 |
Sentence |
denotes |
It has been suggested that the enhanced sensitivity of osteoclast precursors for 1,25-(OH)2D3 in Paget's disease results from increased expression of coactivators of vitamin D receptor (VDR). |
| T9 |
973-1164 |
Sentence |
denotes |
It has been suggested that the enhanced sensitivity of osteoclast precursors for 1,25-(OH)2D3 in Paget's disease results from increased expression of coactivators of vitamin D receptor (VDR). |
| TextSentencer_T10 |
1165-1338 |
Sentence |
denotes |
However, a cause and effect relationship for the paramyxoviral infection and SQSTM1/p62 gene mutations associated with this disease and osteoclast abnormalities are unclear. |
| T10 |
1165-1338 |
Sentence |
denotes |
However, a cause and effect relationship for the paramyxoviral infection and SQSTM1/p62 gene mutations associated with this disease and osteoclast abnormalities are unclear. |
| TextSentencer_T11 |
1339-1400 |
Sentence |
denotes |
Therefore, the etiology of Paget's disease remains uncertain. |
| T11 |
1339-1400 |
Sentence |
denotes |
Therefore, the etiology of Paget's disease remains uncertain. |